Sacubitril/Valsartan Versus Valsartan in Elderly Patients With Acute Myocardial Infarction and Hypertension: Effects on Ventricular Remodeling and Short-term Prognosis After PCI: A Prospective Randomized Controlled Study
This prospective randomized controlled trial demonstrates that early initiation of sacubitril/valsartan, compared to valsartan, in elderly patients with acute myocardial infarction and hypertension following PCI significantly improves cardiac function, attenuates ventricular remodeling and inflammation, and reduces short-term major adverse cardiovascular events without increasing hypotension risk.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.